Showing results (51-60 of 123) with videos related to
Sort By:
Pageof 13
Expert Review of Neurotherapeutics|April 3, 2024
Profiling lecanemab as a treatment option for Alzheimer's diseaseEmily R Schiller, Bret David Silverglate, George T GrossbergExpert Review of Neurotherapeutics|September 18, 2024
Profiling aducanumab as a treatment option for Alzheimer's disease: an overview of efficacy, safety and tolerabilityShreeya Thussu, Aniketh Naidu, Sindhu Manivannan, et al.Clinics in Geriatric Medicine|March 18, 2004
Electroconvulsive therapy in the elderlySanjeev M Kamat, Philip J Lefevre, George T GrossbergClinics in Geriatric Medicine|July 11, 2017
Rapid Depression Assessment in Geriatric PatientsGeorge T Grossberg, David Beck, Syed Noman Y ZaidiCNS Drugs|April 11, 2021
Pharmacotherapy for Frontotemporal DementiaRita Khoury, Yu Liu, Quratulanne Sheheryar, et al.Clinics in Geriatric Medicine|February 24, 2010
Healthy brain aging: a road mapAbhilash K Desai, George T Grossberg, John T ChibnallJournal of the American Medical Directors Association|July 12, 2005
Unmet visual needs of Alzheimer's disease patients in long-term care facilitiesJames M Koch, Gautam Datta, Sohail Makhdoom, et al.Clinics in Geriatric Medicine|October 20, 2018
Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer DiseaseRoula Al-Dahhak, Rita Khoury, Erum Qazi, et al.Expert Opinion on Drug Metabolism & Toxicology|May 17, 2024
Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer'sTanya Song, Yunfei Wang, Bret David Silverglate, et al.The Primary Care Companion for CNS Disorders|October 7, 2011
Predictors of sustained response to rivastigmine in patients with Alzheimer's disease: a retrospective analysisCarl H Sadowsky, George T Grossberg, Monique Somogyi, et al.Pageof 13